1. Home
  2. EBON vs IRIX Comparison

EBON vs IRIX Comparison

Compare EBON & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

N/A

Current Price

$2.07

Market Cap

19.5M

Sector

Technology

ML Signal

N/A

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.01

Market Cap

18.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBON
IRIX
Founded
2010
1989
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
18.2M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
EBON
IRIX
Price
$2.07
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.0K
49.4K
Earning Date
04-24-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.85
EPS
N/A
N/A
Revenue
N/A
$41,593,000.00
Revenue This Year
N/A
$3.07
Revenue Next Year
N/A
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$0.87
52 Week High
$5.90
$1.65

Technical Indicators

Market Signals
Indicator
EBON
IRIX
Relative Strength Index (RSI) 42.02 41.12
Support Level $1.61 $0.95
Resistance Level $2.64 $1.18
Average True Range (ATR) 0.14 0.03
MACD -0.04 0.00
Stochastic Oscillator 9.37 5.00

Price Performance

Historical Comparison
EBON
IRIX

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: